Fritextsökning
Innehållstyper
-
Cell-free cartilage from Lund could pave the way for new bone transplants
Researchers at Lund University have developed a new method for repairing large bone defects, based on laboratory-engineered, cell-free cartilage grafts. The tec...
-
Bolag positiva till norsk linje för alzheimerläkemedel
Norska myndigheter vill begränsa användningen av nya alzheimerläkemedel till sjukhus och specialister. Representanter för Bioarctic och Eli Lilly anser att det ...
-
ISO 20417 has been updated – what device manufacturers should consider
The new edition of ISO 20417 has been published, further clarifying expectations for information supplied with medical devices. Although not yet harmonized, the...
-
Enhancing Spatial Biology
Enabling easy, reproducible multiplex spatial profiling at scale.
-
List: The companies behind 38 new pharmaceutical substances in the EU
In 2025, the European Medicines Agency (EMA) recommended 104 medicines for approval. Of these, 38 contained a new active substance that had never before been au...
-
Investor Network Backs Early-Stage Nordic Innovation
Life Science Invest is expanding into the Nordic region and has secured SEK 31 million to invest in early-stage research companies. The capital will be invested...
-
”Vi behöver bli bättre på att skryta”
Sverige är starkt inom life science, men kan bli ännu starkare. Sweden Bios vd Jessica Martinsson efterlyser bättre politiska villkor och ett Sverige som vågar ...
-
Novo Nordisk Foundation commits billions to Danish life science incubator
The Novo Nordisk Foundation grants up to DKK 5.5 billion to life science and deep‑tech incubator Bioinnovation Institute (BII) in Copenhagen.
-
Breakthrough devices: Key insights from MDCG 2025-9 guidance
The Medical Device Coordination Group (MDCG) has published guidance MDCG 2025-9 to streamline the pathway for breakthrough devices (BtX) under the EU Medical De...
-
Anocca raises SEK 440 million ahead of clinical cancer trial
Swedish cell therapy biotech Anocca has successfully raised SEK 440 million in a new funding round to support upcoming clinical trials in pancreatic cancer.
-
Wegovy approved in the U.S. for treatment of liver disease
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Novo Nordisk’s drug Wegovy to treat the serious liver condition known as MASH. ...
-
Acne medication may be the solution when hair starts falling out
A treatment originally developed for acne has shown remarkable Phase III results in a completely different area: male-pattern hair loss.
-
Computed tomography in measurement of medical plastic products
Watch the recordings from ZEISS Quality Innovation Summit.
-
Optical inspection made easy
New ZEISS Smartzoom 100 product video.
-
Gothenburg-based Anyo Labs gains ground in the AI race
In a fifty-square-metre space in Gothenburg sits a company aiming to secure its place on one of the world's hottest technological stages: AI-driven drug develop...
-
Oncopeptides: Data bekräftar effekt på multipelt myelom
En ny real world-studie bekräftar effekten och säkerheten för Pepaxti i kombination med dexametason vid behandling av multipelt myelom, uppger Oncopeptides.
-
“There’s no magic wand” – The urgent need for new treatments
One in ten women with recurrent yeast infections develops a stubborn, hard-to-treat condition for which no effective therapies currently exist. At Danderyd Hosp...
-
Collaboration across the Øresund – Camurus enters Danish licensing agreement
Lund‑based Camurus has entered into a collaboration and licensing agreement with Danish company Gubra, which specializes in peptide‑based drug development.
-
Genovis i samarbetsavtal med nederländsk partner
Biotechbolaget Genovis har ingått ett partnerskap med nederländska Single Cell Discoveries för att möjliggöra storskaliga analyser av genuttryck.
-
Positiva resultat för Astra Zenecas KOL-kandidat
Nya fas III-data ger stöd för Astra Zenecas KOL-kandidat. Tozorakimab minskar risken för försämringsperioder hos patienter.
-
“Access to capital increases when there’s an exit”
It remains a tough environment for biotech companies seeking financing – but there is good reason to hope for improvement ahead. That’s the view of Okee William...
-
Anacardio fick USA-patent inom hjärtsvikt
Det svenska biotechbolaget Anacardio har beviljats ett amerikanskt patent till skydd för sin ledande läkemedelskandidat AC01 inom hjärtsvikt.
-
Important notification for IVDR Class C device manufacturers
Deadline for application is quickly approaching; 26 May 2026.
-
Final assembly inspection of medical plastics
Technical paper by ZEISS Medical Industry Solutions.
BREAKING